Sotera Health reports 2023 revenue $1.05B (+4.5%); net income $51M; 2024 outlook 4-6% growth

Sotera Health Co

2023-FY EPS reported $0.18 revenue$1,049,288,000

2023 net revenues $1.05B (+4.5% YoY); net income $51M vs loss of $234M in 2022.
Q4 net revenues $310M (+23.3% YoY); net income $39M vs loss of $320M (incl $408M legal reserve).
2023 Adjusted EBITDA $528M (+4.3%); Adjusted EPS $0.81, down $0.15 from 2022.
Sterigenics segment net revenues $667M (+6.5%); segment income $362M (+6.8%).
Full-year 2024 guidance: 4.0%-6.0% growth for Net Revenues and Adjusted EBITDA.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sotera Health Co updated its FY 2024 guidance (initiated).

Period: FY 2024
Guidance: initiated
Result: guidance update

Exact text from the filing

Full-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.